Pulse Biosciences, Inc. (PLSE) is in Healthcare, Medical Instruments & Supplies, based in United States, listed on NasdaqCM. Market cap 3.56B USD. 52-week range 12.56 to 58.90 USD. Data as of 2026-10-09.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment ...